Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

137 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Human immunodeficiency virus type I-specific CD8+ T cell subset abnormalities in chronic infection persist through effective antiretroviral therapy.
Pohling J, Zipperlen K, Hollett NA, Gallant ME, Grant MD. Pohling J, et al. BMC Infect Dis. 2010 May 25;10:129. doi: 10.1186/1471-2334-10-129. BMC Infect Dis. 2010. PMID: 20500844 Free PMC article.
NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.
Parsons MS, Richard J, Lee WS, Vanderven H, Grant MD, Finzi A, Kent SJ. Parsons MS, et al. AIDS Res Hum Retroviruses. 2016 Oct/Nov;32(10-11):1089-1096. doi: 10.1089/AID.2016.0099. Epub 2016 Sep 7. AIDS Res Hum Retroviruses. 2016. PMID: 27487965
Impact of APOBEC Mutations on CD8+ T Cell Recognition of HIV Epitopes Varies Depending on the Restricting HLA.
Squires KD, Monajemi M, Woodworth CF, Grant MD, Larijani M. Squires KD, et al. J Acquir Immune Defic Syndr. 2015 Oct 1;70(2):172-8. doi: 10.1097/QAI.0000000000000689. J Acquir Immune Defic Syndr. 2015. PMID: 26035050
Immune resilience in HIV-infected individuals seronegative for cytomegalovirus.
Barrett L, Stapleton SN, Fudge NJ, Grant MD. Barrett L, et al. AIDS. 2014 Sep 10;28(14):2045-9. doi: 10.1097/QAD.0000000000000405. AIDS. 2014. PMID: 25265072 Clinical Trial.
Heteroclitic peptides enhance human immunodeficiency virus-specific CD8(+) T cell responses.
Gladney KH, Pohling J, Hollett NA, Zipperlen K, Gallant ME, Grant MD. Gladney KH, et al. Vaccine. 2012 Nov 19;30(49):6997-7004. doi: 10.1016/j.vaccine.2012.09.067. Epub 2012 Oct 8. Vaccine. 2012. PMID: 23059359
137 results
Jump to page
Feedback